Early Assessment of Ovarian Cancer Aggressiveness by Metabolic Imaging

NCT05866679 · clinicaltrials.gov ↗

PHASE1

Phase

SUSPENDED

Status

30

Enrollment

OTHER

Sponsor class

Stopped Suspension

Conditions

Ovarian Cancer

Interventions

DRUG: Hyperpolarized 13-C-pyruvate

Sponsor

M.D. Anderson Cancer Center